Pancreatic cancer: joint efforts with Pancreatic Cancer Europe for more therapies
Brussels - The Anticancer Fund and Pancreatic Cancer Europe, with the support of the European Pancreatic Club, are pleased to announce the upcoming event, titled “Getting Our Act Together - Multistakeholder Meeting on Access to Therapy for Pancreatic Cancer” on 25 June 2024. The purpose of the gathering is to focus on access to treatment for pancreatic cancer patients, and to share best practices to highlight the gaps.
The event aims to bring together leading professionals from diverse fields including oncology, surgery, gastroenterology, pharmacology, patient advocacy, and policy-making. The participants will be encouraged to forge strategies for enhancing treatment access for pancreatic cancer patients.
"The topic of the event says it all. This is a call for leadership in developing specific actions for patients with pancreatic cancer, who deserve the same effective treatments as those developed for many other cancers. This challenge requires the input and dedication of all stakeholders. At the Anticancer Fund, we believe in more clinical trials, based on solid pre-clinical work, including the testing of non-profit making drugs. Our goal is to foster collaboration for research and inform the patients”, says Ilse Rooman, Programme Lead Pancreatic Cancer at the Anticancer Fund.
The purpose is to continue a dialogue initiated in Madrid last year, focusing on the main aspects to address pancreatic cancer research in Europe. This year, the organisers want to commit towards the goal of longer and better lives for pancreatic cancer patients, through treatment access and patient care.
Experts in pancreatic cancer such as Alfredo Carrato of Pancreatic Cancer Europe, Ilse Rooman of the Anticancer Fund, and Enrique Domínguez Muñoz of the European Pancreatic Club will be opening the discussions.
“The Multistakeholder Meeting in Santiago de Compostela will bring together some of the brightest minds in oncology, surgery, patient advocacy, and policy-making. Our goal is to develop actionable strategies that will improve access to life-saving therapies and ultimately enhance the quality of life for pancreatic cancer patients”, says Alfredo Carrato.
Roundtable discussions will encourage specific actions
Structured around several sessions, the programme covers topics like best practices in standard care treatments, the role of clinical trials, holistic treatment approaches, and innovative strategies in patient care.
Each session will be followed by roundtable discussions to define specific actions and identify leads for future initiatives.
The gathering will take place in the historic city of Santiago de Compostela, Spain, aligning with the annual meeting of the European Pancreatic Club.
Thank you
The Anticancer Fund and Pancreatic Cancer Europe are committed to advancing research and improving access to care for pancreatic cancer patients across Europe. This meeting is a significant step towards bridging gaps in care and enhancing treatment protocols through collaborative efforts. We believe joint efforts are key to make a difference, and helping patients confronted with pancreatic cancer. We extend our sincere appreciation to all participants and supporters who are contributing to this important conversation about pancreatic cancer.
Please subscribe for insights
While the meeting is by invitation only, the Anticancer Fund and Pancreatic Cancer Europe will be sharing the outcomes. Interested parties are invited to subscribe for updates, so to receive exclusive post-event materials including a report, with a comprehensive overview of the discussions.
Subscribe to updates from the Anticancer Fund
PROGRAMME OF THE EVENT
Session 1. Patient priorities in treatment
- André Mihaljevic - Universitätsklinikum und Medizinische Fakultät Tübingen - Germany
Session 2. Best practices in identifying treatments
- Paolo Arcidiacono - I.R.C.C.S. Ospedale San Raffaele - Italy
- Marc Besselink - Amsterdam University Medical Centers - Netherlands
Session 3. Best practices in SOC treatments
- Max Heckler - Klinik für Allgemein-, Viszeral- und Transplantationschirurgie Universitätsklinikum Heidelberg - Germany
- Aistė Kielaitė-Gulla - Vilnius University · Clinic of Gastroenterology, Nephrourology and Surgery - Lithuania
- Talia Golan - Sheba Medical Centre - Israel
Session 4. Clinical trials
- Liese Vandeborne - Anticancer Fund - Belgium
- Nicola Murphy - PCUK - United Kingdom
Session 5. Holistic treatments
- Joseph Williams - British Oncology Pharmacy Association - United Kingdom
- Oonagh Griffin - St Vincent’s University Hospital Dublin & University College Dublin
- Paula Ravasco - Catolica medical School - Portugal
- Nicola Murphy - PCUK - United Kingdom
Session 6. Call to actions
- Thomas Seufferlein - Ulm University - Germany
- Alfredo Carrato - Pancreatic Cancer Europe - Spain
- Gabriele Capurso - European Pancreatic Club - Italy
- Patrick Michl - United European Gastroenterology - Germany
- Ana Martins - Digestive Cancers Europe - Belgium
- Francisco Lozano - Cancer Patients Europe - Belgium
- Christelle Bouchart - Institut Jules Bordet- HUB - Belgium
- Violeta Vladimirova Stoyanova-Beninska - Committee for Orphan Medicinal Products at European Medicines Agency - Netherlands
- Ansgar Hebborn - The European Federation of Pharmaceutical Industries and Associations (EFPIA) - Belgium
For more information on the event contents, please contact:
PCE: contact@pancreaticcancereurope.eu
Anticancer Fund: info@anticancerfund.org
For any media inquiries, please contact:
PCE: info@pancreaticcancereurope.eu
Anticancer Fund: saar.sinnaeve@anticancerfund.org